Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Experimental Study of Qualified Health Claims: Consumer Inferences About Monounsaturated Fatty Acids From Olive Oil, EPA and DHA Omega-3 Fatty Acids, and Green Tea, 69134 [E6-20200]
Download as PDF
<![CDATA[
69134
Federal Register / Vol. 71, No. 229 / Wednesday, November 29, 2006 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Court Improvement Program—
New Grants.
OMB No.: 0970–0307.
Description: The President signed the
Deficit Reduction Act of 2005 (DRA),
Public Law 109–171, into law on
February 8, 2006. The law authorizes
and appropriates funds for two new
grants under the Court Improvement
Program in title IV–B, section 438, of the
Social Security Act. The highest State
court in a State with an approved title
IV–E plan is eligible to apply for either
or both of the new grants. The new
grants are for the purposes of (1)
Ensuring that the needs of children are
met in a timely and complete manner
through improved case tracking and
analysis of child welfare cases, and (2)
training judges, attorneys, and other
legal personnel in child welfare cases
and conducting cross-training with
child welfare agency staff and
contractors.
The DRA requires separate
applications for these two new grants.
The annual burden estimates below
describe the estimated annual burden
for the two new grants. The
Administration for Children and
Families (ACF) proposes to collect
Number of
respondents
Instrument
Application .......................................................................................................
Annual Program Report ...................................................................................
Estimated Total Annual Burden
Hours: 7,904.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Attn: Desk Officer for
ACF, E-mail address:
Karen_Y._Matsuoka@omb.eop.gov.
jlentini on PROD1PC65 with NOTICES
Dated: November 21, 2006.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 06–9440 Filed 11–28–06; 8:45 am]
BILLING CODE 4184–01–M
Food and Drug Administration
[Docket No. 2005N–0097]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Experimental Study of Qualified Health
Claims: Consumer Inferences About
Monounsaturated Fatty Acids From
Olive Oil, EPA and DHA Omega-3 Fatty
Acids, and Green Tea
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Experimental Study of Qualified
Health Claims: Consumer Inferences
About Monounsaturated Fatty Acids
From Olive Oil, [eicosapentaenoic acid]
EPA and [docosahexaenoic acid] DHA
Omega-3 Fatty Acids, and Green Tea’’
has been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4659.
In the
Federal Register of May 22, 2006 (71 FR
29340), the agency announced that the
SUPPLEMENTARY INFORMATION:
VerDate Aug<31>2005
15:37 Nov 28, 2006
Jkt 211001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Number of responses per
respondent
52
52
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
information from the States about their
work under these grants (applications,
program reports) by way of a Program
Instruction that was issued on June 15,
2006. This Program Instruction
described the programmatic and fiscal
provisions and reporting requirements
for each of the grants, specified the
application submittal and approval
procedures for the grants for fiscal years
2006 through 2010, and identified
technical resources for use by State
courts during the course of the grants.
ACF will use the information received
to ensure compliance with the DRA and
provide training and technical
assistance to the grantees.
Respondents: State courts.
Annual Burden Estimates:
Average
burden huors
per response
2
2
Total burden
hours
40
36
4,160
3,744
proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0592. The
approval expires on November 30, 2009.
A copy of the supporting statement for
this information collection is available
on the Internet at https://www.fda.gov/
ohrms/dockets.
Dated: November 22, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–20200 Filed 11–28–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Transmissible Spongiform
Encephalopathies Advisory
Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
E:\FR\FM\29NON1.SGM
29NON1
]]>Agencies
[Federal Register Volume 71, Number 229 (Wednesday, November 29, 2006)]
[Notices]
[Page 69134]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20200]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2005N-0097]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Experimental Study of Qualified
Health Claims: Consumer Inferences About Monounsaturated Fatty Acids
From Olive Oil, EPA and DHA Omega-3 Fatty Acids, and Green Tea
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Experimental Study of Qualified
Health Claims: Consumer Inferences About Monounsaturated Fatty Acids
From Olive Oil, [eicosapentaenoic acid] EPA and [docosahexaenoic acid]
DHA Omega-3 Fatty Acids, and Green Tea'' has been approved by the
Office of Management and Budget (OMB) under the Paperwork Reduction Act
of 1995.
FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of the Chief
Information Officer (HFA-250), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-827-4659.
SUPPLEMENTARY INFORMATION: In the Federal Register of May 22, 2006 (71
FR 29340), the agency announced that the proposed information
collection had been submitted to OMB for review and clearance under 44
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid OMB control number. OMB has now approved the
information collection and has assigned OMB control number 0910-0592.
The approval expires on November 30, 2009. A copy of the supporting
statement for this information collection is available on the Internet
at https://www.fda.gov/ohrms/dockets.
Dated: November 22, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-20200 Filed 11-28-06; 8:45 am]
BILLING CODE 4160-01-S
